LNTH - Lantheus Holdings, Inc.
NASDAQ
->
Healthcare
->
Diagnostics & Research
North Billerica,
United States
Type: Equity
LNTH price evolution
LNTH
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $757.02 | $718.28 | $713.66 | |
| Short term investments | ||||
| Net receivables | $329.34 | $372.29 | $337.39 | $284.29 |
| Inventory | $70.83 | $70.52 | $69.76 | $64.03 |
| Total current assets | $1295.71 | $1231.15 | $1148.8 | $1085.82 |
| Long term investments | $116.42 | $138.96 | ||
| Property, plant & equipment | $208.86 | $158.16 | $150.09 | $146.7 |
| Goodwill & intangible assets | $233.43 | $203.24 | $213.17 | |
| Total noncurrent assets | $708.68 | $682.53 | $565.33 | |
| Total investments | $116.42 | $138.96 | ||
| Total assets | $2049.63 | $1939.83 | $1831.33 | $1651.15 |
| Current liabilities | ||||
| Accounts payable | $44.91 | $49.77 | $37.52 | $41.19 |
| Deferred revenue | ||||
| Short long term debt | $0.87 | $0.73 | $0.82 | |
| Total current liabilities | $784.08 | $263.29 | $237.2 | $187.35 |
| Long term debt | $0.61 | $563.19 | $562.47 | $561.67 |
| Total noncurrent liabilities | $649.86 | $648.6 | $647.91 | |
| Total debt | $564.06 | $563.2 | $562.49 | |
| Total liabilities | $869.92 | $913.15 | $885.79 | $835.26 |
| Shareholders' equity | ||||
| Retained earnings | $457.74 | $326.64 | $264.57 | $133.5 |
| Other shareholder equity | -$1.17 | -$1.21 | -$1.18 | -$1.04 |
| Total shareholder equity | $1026.68 | $945.54 | $815.89 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $713.66 | $415.65 | $98.51 | $79.61 |
| Short term investments | ||||
| Net receivables | $284.29 | $213.4 | $89.34 | $54 |
| Inventory | $64.03 | $35.48 | $35.13 | $35.74 |
| Total current assets | $1085.82 | $677.62 | $235.79 | $184.22 |
| Long term investments | ||||
| Property, plant & equipment | $146.7 | $141.2 | $116.77 | $120.17 |
| Goodwill & intangible assets | $213.17 | $376.47 | $409.7 | $434.64 |
| Total noncurrent assets | $565.33 | $643.64 | $627.99 | $685.6 |
| Total investments | ||||
| Total assets | $1651.15 | $1321.26 | $863.78 | $869.82 |
| Current liabilities | ||||
| Accounts payable | $41.19 | $20.56 | $20.79 | $16.28 |
| Deferred revenue | ||||
| Short long term debt | $0.82 | $0.35 | $11.64 | $20.7 |
| Total current liabilities | $187.35 | $247.7 | $90.5 | $80.5 |
| Long term debt | $561.67 | $557.71 | $163.12 | $197.7 |
| Total noncurrent liabilities | $647.91 | $626.41 | $308.85 | $275.11 |
| Total debt | $562.49 | $558.07 | $174.76 | $218.4 |
| Total liabilities | $835.26 | $874.11 | $399.35 | $355.62 |
| Shareholders' equity | ||||
| Retained earnings | $133.5 | -$193.16 | -$221.22 | -$149.95 |
| Other shareholder equity | -$1.04 | -$1.26 | -$0.48 | -$2.05 |
| Total shareholder equity | $815.89 | $447.15 | $464.44 | $514.21 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $378.73 | $394.09 | $369.98 | $354 |
| Cost of revenue | $138.32 | $128.13 | $124.13 | |
| Gross Profit | $242.13 | $255.77 | $241.85 | $229.87 |
| Operating activities | ||||
| Research & development | $60.6 | $48.02 | $16.82 | |
| Selling, general & administrative | $92.44 | $93.44 | $75.56 | |
| Total operating expenses | $108.38 | $153.04 | $135.21 | $92.38 |
| Operating income | $102.73 | $106.64 | $137.49 | |
| Income from continuing operations | ||||
| EBIT | $89.24 | $176.13 | $143.44 | |
| Income tax expense | $45.02 | $22.3 | $40.2 | $35.02 |
| Interest expense | $4.94 | $4.86 | $4.86 | $5.04 |
| Net income | ||||
| Net income | $131.09 | $62.07 | $131.07 | $103.38 |
| Income (for common shares) | $62.07 | $131.07 | $103.38 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1296.43 | $935.06 | $425.21 | $339.41 |
| Cost of revenue | $586.89 | $353.36 | $237.51 | $200.65 |
| Gross Profit | $709.54 | $581.7 | $187.69 | $138.76 |
| Operating activities | ||||
| Research & development | $77.71 | $311.68 | $44.97 | $32.79 |
| Selling, general & administrative | $267.19 | $233.83 | $218.82 | $110.17 |
| Total operating expenses | $344.9 | $545.51 | $248.52 | $142.96 |
| Operating income | $364.64 | $36.2 | -$60.83 | -$4.2 |
| Income from continuing operations | ||||
| EBIT | $430.96 | $33.9 | -$67.29 | -$2 |
| Income tax expense | $84.28 | -$1.35 | -$3.76 | $1.99 |
| Interest expense | $20.02 | $7.18 | $7.75 | $9.48 |
| Net income | ||||
| Net income | $326.66 | $28.07 | -$71.28 | -$13.47 |
| Income (for common shares) | $326.66 | $28.07 | -$71.28 | -$13.47 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $62.07 | $131.07 | $103.38 | |
| Operating activities | ||||
| Depreciation | $14.82 | $15.45 | $15.02 | |
| Business acquisitions & disposals | -$33.91 | -$28 | ||
| Stock-based compensation | $18.48 | $15.38 | $14.17 | |
| Total cash flows from operations | $84.72 | $127.24 | $112.29 | |
| Investing activities | ||||
| Capital expenditures | -$11.18 | -$0.27 | -$12.07 | |
| Investments | -$78.26 | |||
| Total cash flows from investing | -$219.41 | -$45.09 | -$106.53 | -$12.07 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.55 | $2.76 | $0.35 | |
| Net borrowings | -$0.44 | -$0.18 | -$0.03 | |
| Total cash flows from financing | -$14.88 | $0.1 | -$16.84 | -$0.45 |
| Effect of exchange rate | $0.03 | -$0.98 | $0.77 | -$0.23 |
| Change in cash and equivalents | $152.76 | $38.75 | $4.63 | $99.54 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $326.66 | $28.07 | -$71.28 | -$13.47 |
| Operating activities | ||||
| Depreciation | $60.04 | $47.93 | $42.29 | $24.69 |
| Business acquisitions & disposals | $52.49 | -$258.2 | $15.82 | $17.56 |
| Stock-based compensation | $50.51 | $29.26 | $15.93 | $14.07 |
| Total cash flows from operations | $305.26 | $281.78 | $53.92 | $16.4 |
| Investing activities | ||||
| Capital expenditures | -$46.55 | -$18.35 | -$12.14 | -$12.47 |
| Investments | -$10 | |||
| Total cash flows from investing | $5.94 | -$276.55 | $3.68 | -$4.91 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $5.75 | -$66.09 | $6.06 | $0.76 |
| Net borrowings | -$0.72 | $382.27 | -$43.35 | -$15.49 |
| Total cash flows from financing | -$13.06 | $311.69 | -$39.33 | -$21.86 |
| Effect of exchange rate | -$0.09 | -$0.34 | -$0.31 | $0.15 |
| Change in cash and equivalents | $298.04 | $316.59 | $17.96 | -$10.22 |
News
Fundamentals
| Market cap | $4.59B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 69.52M |
| Revenue | $1.50B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $427.61M |
| Revenue Q/Q | 18.37% |
| Revenue Y/Y | 24.15% |
| P/E ratio | 10.73 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 3.07 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $6.15 |
|---|---|
| ROA | 22.89% |
| ROE | N/A |
| Debt/Equity | 1.02 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.65 |
| Quick ratio | 1.56 |